PIA
HAE icon

Piedmont Investment Advisors’s Haemonetics HAE Stock Holding History

Piedmont Investment Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,657
Closed -$464K – 293
2020
Q1 		$464K Sell
4,657
-7
-0.2% -$759 0.02% 456
2019
Q4 		$536K Sell
4,664
-736
-14% -$89.1K 0.02% 492
2019
Q3 		$681K Sell
5,400
-1,145
-17% -$145K 0.03% 415
2019
Q2 		$788K Buy
6,545
+3,629
+124% +$357K 0.03% 385
2019
Q1 		$255K Buy
2,916
+646
+28% +$58.7K 0.01% 915
2018
Q4 		$227K Buy
+2,270
New +$238K 0.01% 882
2018
Q3 		– Sell
-933
Closed -$84K – 1563
2018
Q2 		$84K Sell
933
-10,491
-92% -$886K ﹤0.01% 1133
2018
Q1 		$836K Buy
11,424
+567
+5% +$38.9K 0.02% 329
2017
Q4 		$631K Sell
10,857
-602
-5% -$31.7K 0.01% 361
2017
Q3 		$514K Buy
11,459
+115
+1% +$4.78K 0.01% 418
2017
Q2 		$448K Buy
+11,344
New +$466K 0.01% 442

Other funds holding HAE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Piedmont Investment Advisors's HAE Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Haemonetics (HAE) in Q2 2020, closing a stake of 4,657 shares — an estimated $464K sold.

Piedmont Investment Advisors first reported a position in HAE in Q2 2017 and held it in 11 quarters. The position peaked at $836K in Q1 2018. 285 funds tracked by Wall St. Rank hold HAE as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining Haemonetics position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 4,657 Haemonetics shares in Q2 2020, an estimated $464K.
  • Piedmont Investment Advisors first reported a position in Haemonetics in Q2 2017 and held it in 11 quarters.
  • Piedmont Investment Advisors's Haemonetics position peaked at $836K in Q1 2018.
  • 285 funds tracked by Wall St. Rank held Haemonetics as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.